<DOC>
	<DOCNO>NCT02869009</DOCNO>
	<brief_summary>The risk early recurrence progression acute ischemic stroke high , even patient treat aspirin . The Chance study show clopidogrel plus aspirin treatment reduce risk recurrent stroke patient transient ischemic attack ( TIA ) minor ischemic stroke ( NIHSS ≤ 3 ) within 24 hour onset associate increased hemorrhage event , compare aspirin monotherapy . However , know whether dual antiplatelet treatment could reduce risk early recurrence progression patient acute mild moderate ischemic stroke ( 4 ≤ NIHSS ≤ 10 ) . The investigator hypothesise clopidogrel-aspirin treatment superior aspirin monotherapy group patient .</brief_summary>
	<brief_title>Antiplatelet Therapy Acute Mild-Moderate Ischemic Stroke</brief_title>
	<detailed_description>The ATAMIS study multicentre , prospective , randomised , open-label , controlled trial target enrollment 3,000 patient 60 centre Northeast China . Eligible patient follow : ( 1 ) definite acute ischemic stroke ; ( 2 ) neurological deficit : 4 ≤ NIHSS ≤ 10 ; ( 3 ) time onset drug treatment : within 48 hour . Patients clopidogrel-aspirin group receive 300mg load dose clopidogrel , follow clopidogrel 75 mg/d aspirin 75 mg/d day 2 day 14 , follow clopidogrel 75 mg/d aspirin 100 mg/d day 15 day 90 . Patients aspirin-alone group receive 100-300 mg aspirin day 1 day 14 , follow aspirin 100 mg/d day 15 day 90 . The primary efficacy end point early neurological deterioration assess change NIHSS : change NIHSS within 14 day .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Age ≥ 18 year Acute ischemic stroke randomize within 48 hour symptom onset neurological deficit : 4 ≤ NIHSS ≤ 10 CT MRI scan ruling hemorrhage pathology first onset ischemic stroke previous stroke obvious sequela ( mRS≤1 ) Signed informed consent patient self legally authorize representative intracranial hemorrhage hemorrhagic cerebral infarction Thrombolysis ischemic stroke Allergy clopidogrel and/or aspirin History stroke serious sequela Severe systemic disease ( severe infection , severe hepatic renal dysfunction ) Clear indication anticoagulation ( atrial fibrillation , mechanical cardiac valve , deep venous thrombosis , pulmonary embolism ) History intracranial hemorrhage Planned treatment nonsteroidal antiinflammatory drug affect platelet function Anticoagulation within 10 day Gastrointestinal bleed major surgery within 3 month Planned likely revascularization ( angioplasty vascular surgery ) within next 3 month Planned surgery intervention stop antiplatelet therapy Ischemic stroke induce angiography surgery Pregnancy childbirth within previous 4 week Patients treat investigational drug within 3 month enrollment Severe noncardiovascular comorbidity life expectancy &lt; 3 month Any condition situation , opinion investigator , might pose risk patient confound result study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>stroke</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>antiplatelets</keyword>
</DOC>